Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Toxicity to reproduction

Currently viewing:

Administrative data

Endpoint:
screening for reproductive / developmental toxicity
Type of information:
experimental study
Adequacy of study:
weight of evidence
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
comparable to guideline study with acceptable restrictions

Data source

Reference
Reference Type:
publication
Title:
Subchronic Toxicity of Barium Chloride Dihydrate Administered to Rats and Mice in the Drinking Water
Author:
D.D. Dietz, M.R, Elwell, W.E. Davis, Jr., E.F. Meirhenry
Year:
1992
Bibliographic source:
Fundamental and Applied Toxicology 19, 527-537

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 421 (Reproduction / Developmental Toxicity Screening Test)
Version / remarks:
adopted: 29 July 2016
Deviations:
yes
Remarks:
limited documentation
GLP compliance:
not specified
Limit test:
no

Test material

Constituent 1
Reference substance name:
Barium chloride dihydrate
IUPAC Name:
Barium chloride dihydrate
Test material form:
solid
Details on test material:
- State of aggregation: solid, white crystalline
- purity: 99 - 100%
- Lot/batch No.: 123120 and 423103 (obtained from J.T. Baker Chemical Company, Phillipsburg, NJ, USA)

Test animals

Species:
rat
Strain:
Fischer 344
Remarks:
Fischer 344/N
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Simonsen Laboratories, Inc., Gilroy, CA, USA
- Age at study initiation: not specified
- Weight at study initiation: not specified
- Housing: 5 per cage (polycarbonate cages)
- Diet: ad libitum (NIH-07 open-formula pellets diet; Zeigler Brothers, Inc., Gardners, PA, USA)
- Water: ad libitum
- Acclimation period: 10 -11 days

DETAILS OF FOOD AND WATER QUALITY: diet contains less than 20 ppb barium

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 - 24
- Humidity (%): 40 - 62
- Air changes (per hr): 13.5
- Photoperiod (hrs dark / hrs light): 12/12

Administration / exposure

Route of administration:
oral: drinking water
Vehicle:
water
Details on exposure:
PREPARATION OF DOSING SOLUTIONS: no details provided

Details on mating procedure:
- M/F ratio per cage: 1/1
- Length of cohabitation: 1 week
- Proof of pregnancy: sperm in vaginal smear

Analytical verification of doses or concentrations:
not specified
Duration of treatment / exposure:
males: 60 days prior to mating
females: 30 days prior to mating
Frequency of treatment:
continuously
Doses / concentrationsopen allclose all
Dose / conc.:
1 000 ppm (nominal)
Remarks:
corresponding to 65 mg barium/kg bw/day for males and females
Dose / conc.:
2 000 ppm (nominal)
Remarks:
corresponding to 110 or 115 mg barium/kg bw/day for males or females, respectively
Dose / conc.:
4 000 ppm (nominal)
Remarks:
corresponding to 200 or 180 mg barium/kg bw/day for males or females, respectively
No. of animals per sex per dose:
20
Control animals:
yes, plain diet

Examinations

Parental animals: Observations and examinations:
CAGE SIDE OBSERVATIONS: No data

DETAILED CLINICAL OBSERVATIONS: No data

BODY WEIGHT: Yes
- Time schedule for examinations: females were weighed when evidence of mating was found and on day of parturition

FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study):
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: No
- Compound intake calculated as time-weighted averages from the consumption and body weight gain data: No

WATER CONSUMPTION AND COMPOUND INTAKE (if drinking water study): No data
Oestrous cyclicity (parental animals):
no data
Sperm parameters (parental animals):
Parameters examined in all P male parental generations:
testis weight, epididymis weight, sperm motility, sperm morphology, density, and motility
Litter observations:
PARAMETERS EXAMINED
The following parameters were examined in F1 offspring:
number and sex of pups, stillbirths, live births, postnatal mortality, presence of gross anomalies, weight gain

GROSS EXAMINATION OF DEAD PUPS:
yes, for external abnormalities; possible cause of death was not determined for pups born or found dead.

ASSESSMENT OF DEVELOPMENTAL NEUROTOXICITY: no

ASSESSMENT OF DEVELOPMENTAL IMMUNOTOXICITY: no
Postmortem examinations (parental animals):
SACRIFICE
- Male animals: not specified
- Maternal animals: All surviving animals on Days 96 and 97

GROSS NECROPSY
- Gross necropsy consisted of examination of vagina, cervix, oviducts, and ovaries. Implantation sites in the uteri were counted.

HISTOPATHOLOGY / ORGAN WEIGHTS
no data
Postmortem examinations (offspring):
SACRIFICE
- All offsprings were sacrificed at 5 days of age.
- These animals were subjected to postmortem examinations (macroscopic examination) for external abnormalities.

GROSS NECROPSY
- Gross necropsy consisted of external examinations.

HISTOPATHOLOGY / ORGAN WEIGTHS
not examined
Statistics:
Each parameter for which individual values were available was subjected to a linear least squares regression over the dose levels and the direction of the slope and the p value indicating the significance of the deviation of the slope from 0 was determined. Group means and standard deviations or standard errors were calculated for continuous variables. The multiple comparison procedure of Dunnett was employed for pairwise comparisons of these variables between dosed groups and controls. Fisher's exact test was used to make pairwise comparisons of discrete variables between dosed groups and controls and the Cochran-Armitage test was used to assess the significance of dose-related trends. Temporal and dose-related variations were evaluated using a repeated measures analysis of variance. When a collection of measurements were made on each animal, a multivariate analysis of variance was used to test for the simultaneous equality of measurements across dose levels.
Reproductive indices:
No indices calculated, but gestation lenght was estimated.

Results and discussion

Results: P0 (first parental generation)

General toxicity (P0)

Clinical signs:
not specified
Dermal irritation (if dermal study):
not examined
Mortality:
mortality observed, treatment-related
Description (incidence):
one female animal was terminated in a moribund state 21 days after mating
Body weight and weight changes:
not specified
Food consumption and compound intake (if feeding study):
not examined
Food efficiency:
not examined
Water consumption and compound intake (if drinking water study):
not specified
Ophthalmological findings:
not examined
Haematological findings:
not examined
Clinical biochemistry findings:
not examined
Urinalysis findings:
not examined
Behaviour (functional findings):
not examined
Immunological findings:
not examined
Organ weight findings including organ / body weight ratios:
no effects observed
Histopathological findings: non-neoplastic:
no effects observed
Description (incidence and severity):
No effect of the test substance could be detected on vaginal cytology.
Histopathological findings: neoplastic:
not examined
Other effects:
not examined

Reproductive function / performance (P0)

Reproductive function: oestrous cycle:
not examined
Reproductive function: sperm measures:
no effects observed
Description (incidence and severity):
No effect of the test substance could be detected on epididymal sperm counts, sperm motility, and sperm morphology.
Reproductive performance:
no effects observed
Description (incidence and severity):
Although the pregnancy rates (from 40% in controls to 65% in the 4000 ppm group) were below the generally accepted norms for reproduction studies, this problem was not corrected by remating due to restrictions in the study dosing schedule/design. All pregnant dams produced live litters except for one in the 4000 ppm group which was terminated in a moribund state 21 days after mating. The average gestation period of surviving dams was 22 to 22.5 days in the various groups. The average live litter size at birth and on Postpartum Day 5 was marginally reduced in the high-dose group (4000 ppm) rats compared with controls (Day 0, 9.0 ± 1.37 pups compared to 7.2 ± 0.52 pups; Day 5, 9.3 ± 1.16 pups compared to 7 .1 ± 0.56 pups; mean ± SEM) but not statistical significant (p < 0.05). The number of implants per pregnant dam was also marginally reduced from 9.6 ± 1.10 pups in controls to 7.7 ± 0.52 pups in the high-dose group and statistical significant (p < 0.05).

Details on results (P0)

Drinking water containing 1000, 2000, or 4000 ppm barium chloride dihydrate was estimated to deliver daily doses of 65, 110, or 200 mg barium/kg bw to male and 65, 115, or 180 mg barium/kg bw to female rats.

Effect levels (P0)

Key result
Dose descriptor:
NOAEL
Effect level:
>= 4 000 ppm (nominal)
Based on:
test mat.
Remarks:
equivalent to 200 or 180 mg barium/kg bw/day for male and female rats, respectively
Sex:
male/female
Basis for effect level:
other: no effects observed up to highest dose tested

Target system / organ toxicity (P0)

Key result
Critical effects observed:
no

Results: F1 generation

General toxicity (F1)

Clinical signs:
not specified
Dermal irritation (if dermal study):
not examined
Mortality / viability:
no mortality observed
Description (incidence and severity):
Pup survival to Day 5 was 99% or greater in all rat treatment groups.
Body weight and weight changes:
effects observed, treatment-related
Description (incidence and severity):
In the high-dose group, the live pup weight at birth (5.20 ± 0.06 g) was significantly less (p < 0.01) than the control values (5.70 ± 0.09 g). A comparison of pup weights on Day 5 (9.93 ± 0.20 g for high dose compared to 10.55 ± 0.26 g for controls) failed to show significant changes. Weight gain during this period, however, was comparable among all pup groups.
Food consumption and compound intake (if feeding study):
not examined
Food efficiency:
not examined
Water consumption and compound intake (if drinking water study):
not examined
Ophthalmological findings:
not examined
Haematological findings:
not examined
Clinical biochemistry findings:
not examined
Urinalysis findings:
not examined
Sexual maturation:
not examined
Organ weight findings including organ / body weight ratios:
not examined
Gross pathological findings:
no effects observed
Description (incidence and severity):
No external abnormalities were observed in the rat offspring.
Histopathological findings:
not examined
Other effects:
not examined

Developmental neurotoxicity (F1)

Behaviour (functional findings):
not examined

Developmental immunotoxicity (F1)

Developmental immunotoxicity:
not examined

Effect levels (F1)

Key result
Dose descriptor:
NOAEL
Generation:
F1
Effect level:
>= 4 000 ppm (nominal)
Based on:
test mat.
Sex:
male/female
Basis for effect level:
other: no effects observed up to highest dose tested

Target system / organ toxicity (F1)

Key result
Critical effects observed:
no

Overall reproductive toxicity

Key result
Reproductive effects observed:
no

Applicant's summary and conclusion

Conclusions:
Taken together all data of this study, there are no indications of a substantial impairment of fertility in rats up to the highest dose tested. Thus, the NOAEL was 4000 ppm (to average doses of 200 and 170 mg barium/kg bw/d to male and and female rats, respectively). NOAELs on developmental toxicity for rats of 4000 ppm were derived from this study. However, this NOAEL is of limited value to evaluate the potential for barium to induce developmental effects because there was no exposure of the females during gestation.